MedTrace Logo

Inspiratory Muscle Training in Patients Receiving Allogenic Stem Cell Transplantation

NCT01281410 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2011-07-04

No results posted yet for this study

Summary

The study is a monocentric, controlled randomized trial. Its an interventional method study. There is a control and an interventional group. The interventional group is receiving a specific inspiratory muscle training with "Respifit" (special device for inspiratory muscle training) during the first 30 days after allogenic stem cell transplantation.

The investigators want to show that the training group gets stronger inspiratory muscles. The investigators measure the change of PIMAX values and MVV values.

Conditions

  • Inspiratory Muscle Training
  • Stem Cell Transplantation
  • Respiratory Muscle Training

Interventions

PROCEDURE

Inspiratory Muscle Training

Inspiratory Muscle Training with Respifit (5 times per week)

OTHER

inspiratory muscle training

Inspiratory muscle training with a device named Respifit for patients receiving a hematopoetic stem cell transplantation (till 30 days after their transplantation)

Sponsors & Collaborators

  • Elisabethinen Hospital

    lead OTHER

Principal Investigators

  • Hanns Hauser, MD · Elisabethinen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01281410 on ClinicalTrials.gov